Prognostix
Get Full AccessDescription
- PrognostiX, a privately-held spin out of the Cleveland Clinic Foundation, is focused on cardiovascular disease management. The company's CardioMPO test, which aids in the diagnosis of near-term heart attack and cardiac death risk is the first FDA-cleared diagnostic of its kind. PrognostiX's proprietary product pipeline includes valuable, high-margin cardiovascular and inflammatory biomarkers licensed to it exclusively by the Cleveland Clinic, the world's most respected cardiovascular center. The company operates a CLIA-certified and CAP-accredited specialty reference laboratory, enabling it to bring promising new cardiovascular biomarkers to market
-
Headquarters: , , Ohio, United States
More -
Phone Number:
-
Website: https://www.prognostix.com
-
Employees:4
-
Revenue:$1 - 10M
-
Legal Name:Prognostix
-
Prognostix's Social Media
-
Is this data correct?
-
| NAICS Code: 621330 |
Show More
Frequently Asked Questions regarding Prognostix
-
What is Prognostix's official website?
Prognostix's official website is https://www.prognostix.com
-
What is Prognostix's Revenue?
Prognostix's revenue is $1 - 10M
-
What is Prognostix's NAICS code?
Prognostix's NAICS code is 621330
-
How many employees are working in Prognostix
Prognostix has 4 employees
-
What is Prognostix's Industry?
Prognostix is in the industry of Health, Wellness And Fitness
-
Who is Prognostix's CEO?
Prognostix's CEO is Mark Willig

